These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24043968)

  • 21. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation.
    Li X; Xu M; Liu M; Tan Y; Zhuang B; Lin M; Kuang M; Xie X
    Int J Hyperthermia; 2020; 37(1):1016-1026. PubMed ID: 32865050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography.
    Makino Y; Imai Y; Ohama H; Igura T; Kogita S; Sawai Y; Fukuda K; Takamura M; Ohashi H; Murakami T
    Oncology; 2013; 84 Suppl 1():44-50. PubMed ID: 23428858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
    Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
    Rhim H; Choi D; Kim YS; Lim HK; Choe BK
    Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
    Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
    Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
    Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
    Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced ultrasonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta-analysis.
    Shi W; He Y; Ding W; Gong S; Wang Y; Xiao J; He B
    Br J Radiol; 2016 Aug; 89(1064):20150973. PubMed ID: 27327401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
    Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas.
    Lee J; Lee JM; Yoon JH; Lee JY; Kim SH; Lee JE; Han JK; Choi BI
    Korean J Radiol; 2012; 13(1):34-43. PubMed ID: 22247634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
    Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
    World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.
    Chen MH; Wu W; Yang W; Dai Y; Gao W; Yin SS; Yan K
    J Ultrasound Med; 2007 Aug; 26(8):1055-63. PubMed ID: 17646367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
    Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ
    J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1-3 cm): value of fusion imaging with conventional US and CT/MR images.
    Lee MW; Rhim H; Cha DI; Kim YJ; Lim HK
    J Vasc Interv Radiol; 2013 Jul; 24(7):958-65. PubMed ID: 23796082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.
    Liu F; Yu X; Liang P; Cheng Z; Han Z; Dong B
    Int J Hyperthermia; 2011; 27(6):555-62. PubMed ID: 21797695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
    Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
    Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
    Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.